Deborah Borg - Oct 20, 2021 Form 4 Insider Report for BUNGELTD (BG)

Role
EVP & Chief HR, Comms Officer
Signature
Drew Yaeger, Attorney-in-Fact
Stock symbol
BG
Transactions as of
Oct 20, 2021
Transactions value $
-$22,796
Form type
4
Date filed
10/22/2021, 07:25 PM
Previous filing
Oct 1, 2021
Next filing
Oct 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BG Common Stock Options Exercise $25.1K +501 +0.96% $50.07 52.9K Oct 20, 2021 Direct F1
transaction BG Common Stock Sale -$35.2K -400 -0.76% $88.00 52.5K Oct 20, 2021 Direct F1, F2
transaction BG Common Stock Options Exercise $31.3K +626 +1.19% $50.07 53.1K Oct 21, 2021 Direct F1
transaction BG Common Stock Sale -$44K -500 -0.94% $88.05 52.6K Oct 21, 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BG Stock Option (Right to Buy) Options Exercise $0 -501 -1.7% $0.00 29K Oct 20, 2021 Common Stock 501 $50.07 Direct F1, F4
transaction BG Stock Option (Right to Buy) Options Exercise $0 -626 -2.16% $0.00 28.4K Oct 21, 2021 Common Stock 626 $50.07 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2021.
F2 Shares were sold for the purpose of the payment of tax liability incident to the exercise of stock options.
F3 This transaction was executed in multiple trades at prices ranging from $88.00 to $88.14. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Limited, any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 This option was granted on March 1, 2016 and became exercisable in three equal annual installments beginning on March 1, 2017.